These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26753400)

  • 41. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A
    Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uric acid levels correlate with baseline renal function and high levels are a potent risk factor for postoperative chronic kidney disease in patients with renal cell carcinoma.
    Jeon HG; Choo SH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Urol; 2013 Apr; 189(4):1249-54. PubMed ID: 23159461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
    Patel AR; Dombrovskiy VY; Vogel TR
    Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
    Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives.
    López-Novoa JM; Martínez-Salgado C; Rodríguez-Peña AB; López-Hernández FJ
    Pharmacol Ther; 2010 Oct; 128(1):61-81. PubMed ID: 20600306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathophysiology of diabetic nephropathy.
    Sego S
    Nephrol Nurs J; 2007; 34(6):631-3. PubMed ID: 18203571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The renin-angiotensin system from conception to old age: the good, the bad and the ugly.
    Lumbers ER; Pringle KG; Wang Y; Gibson KJ
    Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):743-52. PubMed ID: 24164175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
    Rust P; Ekmekcioglu C
    Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of renal function in elderly patients.
    Fliser D
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):604-8. PubMed ID: 18941354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.
    Malmgren L; McGuigan FE; Berglundh S; Westman K; Christensson A; Åkesson K
    Nephron; 2015; 130(4):245-55. PubMed ID: 26184510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.
    Afghahi H; Miftaraj M; Svensson AM; Hadimeri H; Gudbjörnsdottir S; Eliasson B; Svensson MK;
    J Diabetes Complications; 2013; 27(3):229-34. PubMed ID: 23246248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.
    Hallan SI; Dahl K; Oien CM; Grootendorst DC; Aasberg A; Holmen J; Dekker FW
    BMJ; 2006 Nov; 333(7577):1047. PubMed ID: 17062598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The current management of kidney disease in the elderly.
    Perkowska-Ptasinska A; Deborska-Materkowska D; Durlik M
    Minerva Med; 2018 Feb; 109(1):41-52. PubMed ID: 28750501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The aging kidney revisited: a systematic review.
    Bolignano D; Mattace-Raso F; Sijbrands EJ; Zoccali C
    Ageing Res Rev; 2014 Mar; 14():65-80. PubMed ID: 24548926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The detection of chronic kidney disease, a caregiver-user collaboration].
    Couat C
    Soins; 2018 Jun; 63(826):46-48. PubMed ID: 29958583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal function and renal disease in the elderly: Part I.
    Mulder WJ; Hillen HF
    Eur J Intern Med; 2001 Apr; 12(2):86-97. PubMed ID: 11297910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.